Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00775931 · ClinicalTrials.gov registry record · Phase 2
Allogeneic Transplantation For Severe Osteopetrosis
A Phase 2 study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00775931: Completed Phase 2 study, sponsored by Masonic Cancer Center, University of Minnesota.
NCT00775931 is a Phase 2 study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 7 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00775931, a Phase 2 study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this research is to explore what we believe may be a safer and more effective means of performing stem cell transplantation in patients with Osteopetrosis, using chemotherapy and radiation designed to bring about engraftment and lessen transplant mortality. Prior multi-institutional data in past studies found that approximately 30% of Osteopetrosis patients do not engraft. Therefore, in this study, we utilize a reduced intensity design of pre-transplant drugs to try to make transplants safer for this disease, as well as to provide a second infusion of stem cells in patients with matched related or unrelated donors.
Interventions
- DRUG Cyclophosphamide
- DRUG Busulfan
- PROCEDURE umbilical cord blood transplantation
- DRUG Campath-1H
- RADIATION Total Lymphoid Irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
What the finished NCT00775931 record still lists
NCT00775931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 5 interventions - of which Cyclophosphamide is the first listed.
NCT00775931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00775931 about?
NCT00775931 is a clinical study titled "Allogeneic Transplantation For Severe Osteopetrosis". The purpose of this research is to explore what we believe may be a safer and more effective means of performing stem cell transplantation in patients with Osteopetrosis, using chemotherapy and radiation designed to bring about engraftment and lessen transplant mortality. Prior multi-institutional d...
What is the current status of trial NCT00775931?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2008-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00775931?
The interventions under investigation include: Cyclophosphamide (DRUG), Busulfan (DRUG), umbilical cord blood transplantation (PROCEDURE), Campath-1H (DRUG), Total Lymphoid Irradiation (RADIATION).
Who is sponsoring clinical trial NCT00775931?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00775931's enrollment target sits among peer trials
7 1996th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia